Eurand to Present at Barclays Capital Global Healthcare Conference
PHILADELPHIA, PA, Mar 10, 2010 (MARKETWIRE via COMTEX News Network) -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Barclays Capital 2010 Global Healthcare Conference. Gearoid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.
Date: Wednesday, March 24, 2010
Time: 10:15 a.m. ET
Location: Loews Hotel, Miami, Fla.
An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's website at www.eurand.com. A replay of the presentation will be available for 30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking/ orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.
Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email Contact
SOURCE: Eurand N.V.
http://www2.marketwire.com/mw/emailprcntct?id=9A7D58B2905DEC6A http://www2.marketwire.com/mw/emailprcntct?id=1D64542D78B7B75C http://www2.marketwire.com/mw/emailprcntct?id=F31FA52965E9B7C6
Copyright 2010 Marketwire, Inc., All rights reserved.
News Provided by COMTEX